| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |